SV2B/miR-34a/miR-128 axis as prognostic biomarker in glioblastoma multiforme
Abstract Glioblastoma (GBM) is a heterogenous primary brain tumour that is characterised with unfavourable patient prognosis. The identification of biomarkers for managing brain malignancies is of utmost importance. MicroRNAs (miRNAs) are small, non-coding RNAs implicated in cancer development. This...
Main Authors: | D. Mustafov, S. S. Siddiqui, L. Klena, E. Karteris, M. Braoudaki |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-03-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-024-55917-6 |
Similar Items
-
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
by: Qiu Shuwei, et al.
Published: (2013-01-01) -
MiR-128-3p Regulates Proliferation, Migration and Apoptosis of Glioblastoma Multiforme by Targeting HOXA5
by: YANG Jipeng, et al.
Published: (2021-01-01) -
MiR-181 Family Modulates Osteopontin in Glioblastoma Multiforme
by: Anantha Marisetty, et al.
Published: (2020-12-01) -
MiR-21, miR-34a, miR-125b, miR-181d and miR-648 levels inversely correlate with MGMT and TP53 expression in primary glioblastoma patients
by: Dorota Jesionek-Kupnicka, et al.
Published: (2019-03-01) -
The Role of miR-128 in Neurodegenerative Diseases
by: Marika Lanza, et al.
Published: (2023-03-01)